Activation of Progelatinase A and Progelatinase A/TIMP-2 Complex by Membrane Type 2-Matrix Metalloproteinase

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Biological chemistry

• Publication date

  1997-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/bchm.1997.378.2.71PMID 9088534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix degrading metalloproteinases

  2005cited by this paper
• The recombinant catalytic domain of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP‐2

  1996cited by this paper
• The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation

  1996cited by this paper
• Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity (*)

  1996cited by this paper
• Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.

  1996cited by this paper
• Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library

  1995cited by this paper
• Furin-dependent intracellular activation of the human stromelysin-3 zymogen

  1995cited by this paper
• The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A Activation (*)

  1995cited by this paper
• cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment.

  1995cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Generation and activity of the ternary gelatinase B/TIMP-1/LMW-stromelysin-1 complex.

  1995cited by this paper
• The Family of Matrix Metalloproteinasesa

  1994cited by this paper
• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• The family of matrix metalloproteinases.

  1994cited by this paper
• High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development

  1994cited by this paper
• Isolation of latent 31-kDa C-truncated stromelysin and 21-kDa stromelysin from rabbit synovial fibroblasts: an alternative activation pathway for stromelysin.

  1994cited by this paper
• Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence

  1994cited by this paper
• Residential radon exposure and lung cancer—an epidemiological study of Norwegian municipalities

  1994cited by this paper
• Activity of ternary gelatinase A-TIMP-2-matrix metallo-proteinase complexes.

  1994cited by this paper
• High Expression of 92‐kDa Type IV Collagenase (Gelatinase) in the Osteoclast Lineage during Mouse Development

  1994cited by this paper
• Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B)

  1993cited by this paper
• Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.

  1993cited by this paper
• The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.

  1993cited by this paper
• Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme.

  1993cited by this paper
• Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.

  1991cited by this paper
• The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor.

  1991cited by this paper
• Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

  1990cited by this paper
• Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases.

  1990cited by this paper
• Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

  1989cited by this paper
• SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

  1989cited by this paper
• Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

  1989cited by this paper
• Identification and characterization of enamel proteinases isolated from developing enamel. Amelogeninolytic serine proteinases are associated with enamel maturation in pig.

  1988cited by this paper
• Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

  1985cited by this paper
• Synthetic substrates for vertebrate collagenase.

  1977cited by this paper

• The relationship between MMP-2 and TIMP-2 gene polymorphisms and skin barrier function, inflammatory cytokine levels in acne patients.

  2026cites this paper
• Biophysical evidence for differential gallated green tea catechins binding to membrane type-1 matrix metalloproteinase and its interactors.

  2018cites this paper
• Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition

  2017cites this paper
• Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis

  2016cites this paper
• The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.

  2015cites this paper
• MT2‐MMP Expression During Early Avian Morphogenesis

  2013cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology MMP 15 ( matrix metallopeptidase 15 ( membrane-inserted ) )

  2013cites this paper
• Identificación de biomarcadores diagnósticos y terapéuticos de aneurismas de aorta abdominal mediante nuevas aproximaciones proteómicas

  2012cites this paper
• Physiological Functions of Membrane‐Type Metalloproteases

  2012cites this paper
• Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm.

  2012cites this paper
• EXPRESSION OF MEMBRANE TYPE-2 AND -3 MATRIX METALLOPROTEINASES IN EUTOPIC ENDOMETRIUM OF WOMEN WITH ADVANCED ENDOMETRIOSIS

  2011cites this paper
• Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?

  2009cites this paper
• Regulation of Elastolytic Proteases in the Mouse Vagina During Pregnancy, Parturition, and Puerperium1

  2008cites this paper
• MT3-MMP (MMP-16) is Downregulated by In Vitro Cytokine Stimulation of Cartilage, but Unaltered in Naturally Occurring Equine Osteoarthritis and Osteochondrosis

  2008cites this paper
• Increased MMP‐2 activity during intervertebral disc degeneration is correlated to MMP‐14 levels

  2008cites this paper
• Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.

  2007cites this paper
• Metalloproteinases and human placental invasiveness.

  2006cites this paper
• TIMP Independence of Matrix Metalloproteinase (MMP)-2 Activation by Membrane Type 2 (MT2)-MMP Is Determined by Contributions of Both the MT2-MMP Catalytic and Hemopexin C Domains*

  2006cites this paper
• Membrane‐type 1 matrix metalloproteinase is required for normal alveolar development

  2005cites this paper
• Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways.

  2004cites this paper
• MT1‐MMP: A tethered collagenase

  2004cites this paper
• Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis.

  2004cites this paper
• Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential

  2004cites this paper
• The role of gelatinases in colorectal cancer progression and metastasis.

  2004cites this paper
• Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features.

  2004cites this paper
• Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3

  2004cites this paper
• Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.

  2004cites this paper
• Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling.

  2003cites this paper
• Proteases in Tissue Remodelling of Lung and Heart

  2003cites this paper
• Matrix Metalloproteinases and Myocardial Remodeling in Heart Failure

  2003cites this paper
• Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.

  2003cites this paper
• Proteases in brain tumour progression

  2003cites this paper
• Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis.

  2003cites this paper
• Envelope Gene-Mediated Neurovirulence in Feline Immunodeficiency Virus Infection: Induction of Matrix Metalloproteinases and Neuronal Injury

  2002influential citation
• Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)

  2002cites this paper
• Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer.

  2002cites this paper
• Therapeutic developments in matrix metalloproteinase inhibition

  2002cites this paper
• Cellular Activation of MMP-2 (Gelatinase A) by MT2-MMP Occurs via a TIMP-2-independent Pathway*

  2001cites this paper
• Secretion of Gelatinases and Activation of Gelatinase A (MMP-2) by Human Rheumatoid Synovial Fibroblasts

  2001cites this paper
• Activation of Progelatinase A by Mammalian Legumain, a Recently Discovered Cysteine Proteinase

  2001cites this paper
• Substrate recognition by gelatinase A: the C-terminal domain facilitates surface diffusion.

  2001cites this paper
• Expression and localization of transcripts of MT5-MMP and its related MMP in the ovary of the medaka fish Oryzias latipes.

  2001cites this paper
• Activation of Progelatinase A by Mammalian Legumain, a Recently Discovered Cysteine Proteinase

  2001cites this paper
• Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.

  2000cites this paper
• Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP.

  2000cites this paper
• Activation of Progelatinase B by Membranes of Human Polymorphonuclear Granulocytes

  2000cites this paper
• Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis.

  2000cites this paper
• Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A.

  2000cites this paper
• Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis

  1999cites this paper
• Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease.

  1999cites this paper
• Clinical usefblness of serum matrix metalloproteinase-2 in patients with chronic viral liver disease concentration

  1999cites this paper
• Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase.

  1999cites this paper
• Investigation of mechanisms of breast cancer invasion : the role of matrix metalloproteinases and cell adhesion molecules

  1999cites this paper
• Biochemical Characterization of the Catalytic Domain of Membrane-Type 4 Matrix Metalloproteinase

  1999cites this paper
• Expression, purification and charaterization of recombinant mouse MT5‐MMP protein products

  1999cites this paper
• Membrane‐type matrix metalloproteinases

  1999cites this paper
• Matrix Metalloproteinases in the Pathogenesis of Breast Cancer

  1999cites this paper
• Differential Expression of Aggrecanase and Matrix Metalloproteinase Activity in Chondrocytes Isolated from Bovine and Porcine Articular Cartilage*

  1998cites this paper
• The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

  1998cites this paper
• The Involvement of the Fibronectin Type II-like Modules of Human Gelatinase A in Cell Surface Localization and Activation*

  1998cites this paper
• Matrix Metalloproteinases in Remodeling of the Normal and Neoplastic Mammary Gland

  1998cites this paper
• The Propeptide Domain of Membrane Type 1 Matrix Metalloproteinase Is Required for Binding of Tissue Inhibitor of Metalloproteinases and for Activation of Pro-gelatinase A*

  1998cites this paper
• Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.

  1998cites this paper